AU744730B2 - Live vaccine for human immunodeficiency virus - Google Patents

Live vaccine for human immunodeficiency virus Download PDF

Info

Publication number
AU744730B2
AU744730B2 AU31801/99A AU3180199A AU744730B2 AU 744730 B2 AU744730 B2 AU 744730B2 AU 31801/99 A AU31801/99 A AU 31801/99A AU 3180199 A AU3180199 A AU 3180199A AU 744730 B2 AU744730 B2 AU 744730B2
Authority
AU
Australia
Prior art keywords
vaccine
hiv
reverse transcriptase
mice
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31801/99A
Other languages
English (en)
Other versions
AU3180199A (en
Inventor
Mary Susan Burnett
George Barrie Kitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Publication of AU3180199A publication Critical patent/AU3180199A/en
Application granted granted Critical
Publication of AU744730B2 publication Critical patent/AU744730B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
AU31801/99A 1998-02-06 1999-02-04 Live vaccine for human immunodeficiency virus Ceased AU744730B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7394398P 1998-02-06 1998-02-06
US60/073943 1998-02-06
PCT/US1999/002503 WO1999039735A1 (en) 1998-02-06 1999-02-04 Live vaccine for human immunodeficiency virus

Publications (2)

Publication Number Publication Date
AU3180199A AU3180199A (en) 1999-08-23
AU744730B2 true AU744730B2 (en) 2002-02-28

Family

ID=22116747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31801/99A Ceased AU744730B2 (en) 1998-02-06 1999-02-04 Live vaccine for human immunodeficiency virus

Country Status (13)

Country Link
EP (1) EP1061950B1 (enExample)
JP (1) JP2002502827A (enExample)
KR (1) KR20010040618A (enExample)
CN (1) CN1216640C (enExample)
AT (1) ATE287727T1 (enExample)
AU (1) AU744730B2 (enExample)
CA (1) CA2320489A1 (enExample)
DE (1) DE69923439D1 (enExample)
IL (1) IL137680A0 (enExample)
NZ (1) NZ506093A (enExample)
RU (1) RU2223784C2 (enExample)
WO (1) WO1999039735A1 (enExample)
ZA (1) ZA99912B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802426B1 (fr) 1999-12-15 2004-04-02 Neovacs Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires
AU8640501A (en) * 2000-07-31 2002-02-13 Univ Yale Innate immune system-directed vaccines
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
EP1670505B1 (en) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
ES2555544T3 (es) 2006-03-07 2016-01-04 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
CN101195823B (zh) * 2007-11-20 2010-06-02 华东理工大学 细菌表面展示系统、方法及应用
CN109207417A (zh) * 2018-09-19 2019-01-15 湖北省农业科学院畜牧兽医研究所 鸡白痢-j亚群禽白血病双重平板凝集抗原及其制备方法
JP2023516420A (ja) * 2020-03-05 2023-04-19 ユニヴァーシティー オブ メリーランド バルチモア がんタンパク質抗原を発現するように操作された生チフス菌ベクターおよびその使用方法
WO2025063261A1 (ja) * 2023-09-22 2025-03-27 塩野義製薬株式会社 ウイルス由来タンパク質をコードするポリヌクレオチド

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9179891A (en) * 1990-12-19 1992-07-22 Epitope, Inc. Hiv reverse transcriptase vaccine
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
AU3958895A (en) * 1994-10-18 1996-05-06 Board Of Regents, The University Of Texas System Membrane expression of heterologous genes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERGGREN ET AL 95' J. OF ACQ. IMMUNE DEF. SYND. 10(5):489-95 *
HONE ET AL 1996 J. OF BIOTECHNOLOGY 44 (1-3):203-7 *

Also Published As

Publication number Publication date
DE69923439D1 (de) 2005-03-03
ATE287727T1 (de) 2005-02-15
RU2223784C2 (ru) 2004-02-20
CA2320489A1 (en) 1999-08-12
IL137680A0 (en) 2001-10-31
KR20010040618A (ko) 2001-05-15
AU3180199A (en) 1999-08-23
NZ506093A (en) 2003-08-29
EP1061950A1 (en) 2000-12-27
CN1216640C (zh) 2005-08-31
WO1999039735A9 (en) 2000-01-27
EP1061950A4 (en) 2001-12-05
EP1061950B1 (en) 2005-01-26
WO1999039735A1 (en) 1999-08-12
JP2002502827A (ja) 2002-01-29
CN1290175A (zh) 2001-04-04
ZA99912B (en) 2000-08-07

Similar Documents

Publication Publication Date Title
CA2526128C (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
US6210663B1 (en) Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
US5830702A (en) Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
AU2004283300B2 (en) Immunogenic composition and method of developing a vaccine based on Factor H binding sites
AU727015B2 (en) Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
AU729231B2 (en) Synthetic HIV genes
Fensterle et al. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun
JP5502757B2 (ja) ワクチンとしてのキメラｈｉｖ融合タンパク質
US20240156936A1 (en) Live salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof
CN1252075A (zh) 合成的hiv gag基因
CA2258568A1 (en) Vaccines comprising synthetic genes
EA004921B1 (ru) Аттенуированный микроорганизм salmonella и способы его применения
Vajdy et al. Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations
EP1061950B1 (en) Live vaccine for human immunodeficiency virus
CN118434443A (zh) 干扰素在疫苗中作为佐剂的用途
JP2004525931A (ja) バクテリオファージによって仲介される免疫化方法
CZ20013916A3 (cs) Adjuvantní kombinované prostředky
US7189402B1 (en) Live vaccine for human immunodeficiency virus
JPH09504296A (ja) Ｈｉｖ粘膜感染の阻止
US20190389913A1 (en) Method for increasing etec cs6 antigen presentation on cell surface and products obtainable thereof
Hamajima et al. Strong augment effect of IL-12 expression plasmid on the induction of HIV-specific cytotoxic T lymphocyte activity by a peptide vaccine candidate
US20150190501A1 (en) Methods and compositions for raising an immune response to hiv
JP4535874B2 (ja) 肝炎に対するバクテリオファージを介する免疫
Burnett et al. Potential live vaccines for HIV
Vasconcellos et al. Vaccine Against Entheropathogenic E. coli: A Systematic Review

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)